Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB
WHITEHEAD INSTITUTE FOR
BIOMEDICAL RESEARCH, ORDER:
13 Plaintiffs, (1) GRANTING JOINT MOTIONS 14 v. FOR DETERMINATION OF A DISCOVERY DISPUTE; AND SHORELINE BIOSCIENCES, INC.; and
DAN S. KAUFMAN, [Doc. Nos. 248, 249.] Defendants. (2) DENYING PLAINTIFFS’
MOTIONS TO COMPEL WITHOUT
PREJUDICE
20 On April 14, 2023, the parties filed two joint motions for determination of a 21 discovery dispute. (Doc. Nos. 248, 249.) In the first joint filing, Plaintiffs Fate 22 Therapeutics, Inc. (“Fate”) and Whitehead Institute for Biomedical Research 23 (“Whitehead”) request to add Dr. Robert Hollingsworth as an additional ESI custodian 24 pursuant to the Court’s October 12, 2022 order governing discovery of electronically stored 25 information (“ESI Order”). (Doc. No. 248.) Plaintiffs assert that adding…